Top Markets
Coin of the day
BioSig Technologies, Inc. BioSig Technologies, Inc.

BioSig Technologies, Inc.

BSGM
Rank in Stocks #10875
BioSig Technologies, Inc., along with its subsidiaries, operates as a medical... BioSig Technologies, Inc., along with its subsidiaries, operates as a medical technology enterprise. Its core innovation is the PURE EP (precise uninterrupted real-time evaluation of electrograms electrophysiology) system. This proprietary signal processing platform, merging specialized hardware and software, tackles well-known difficulties in electrophysiological signal acquisition, empowering electrophysiologists to instantaneously view and analyze vital cardiac signals. The system further enhances the collection of intracardiac signals and diagnostic data crucial for atrial fibrillation procedures. Moreover, it is specifically engineered to overcome persistent obstacles that traditionally slow down and complicate cardiac catheter ablation. BioSig also holds a research agreement with the University of Minnesota, targeting the development of new treatments for sympathetic nervous system disorders. Additionally, it has a strategic partnership with the Mayo Foundation for Medical Education and Research, focused on creating an advanced AI and machine learning software solution tailored for its PURE EP platforms. Established in 2009, BioSig Technologies, Inc. is headquartered in Westport, Connecticut.
Share Price
$5.52
Last synced: 2025-10-09
Market Cap
$775.10M
Change (1 day)
1.28%
Change (1 year)
15.48%
Country
US
Trade BioSig Technologies, Inc. (BSGM)

Category

P/E ratio for BioSig Technologies, Inc. (BSGM)
P/E ratio as of August 2026 TTM: -4.96
According to BioSig Technologies, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -4.96. At the end of 2023 the company had a P/E ratio of -12.02.
P/E ratio history for BioSig Technologies, Inc. from 2011 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) -4.96 -75.51%
2024 -20.25 68.43%
2023 -12.02 81.27%
2022 -6.63 -72.16%
2021 -23.83 14.23%
2020 -20.86 -42.24%
2019 -36.12 0.60%
2018 -35.90 23.88%
2017 -28.98 33.56%
2016 -21.70 12.40%
2015 -19.31 -39.46%
2014 -31.89 18.97%
2013 -26.81 -97.46%
2012 -1.06K -53.54%
2011 -2.27K 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
35.77 -821.37%
US
34.86 -802.97%
US
21.39 -531.27%
IE
20.90 -521.41%
US
- -
DE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.